Molecular modeling study for the design of novel acetyl-CoA carboxylase inhibitors using 3D QSAR, molecular docking and dynamic simulations

References

• Abdel-Halim, M. N., & Yousufzai, S. Y. K. (1981). Purification and properties of rat liver acetyl coa carboxylase protein inhibitor. International Journal of Biochemistry, 13, 1171–1176. doi:10.1016/0020-711X(81)90210-X
   PubMedGoogle Scholar
• Bhadauriya, A., Dhoke, G. V., Gangwal, R. P., Damre, M. V., & Sangamwar, A. T. (2013). Identification of dual Acetyl-CoA carboxylases 1 and 2 inhibitors by pharmacophore based virtual screening and molecular docking approach. Molecular Diversity, 17, 139–149. doi:10.1007/s11030-013-9425-2
   PubMed Web of Science ®Google Scholar
• Brownsey, R., Boone, A., Elliot, J. E., Kulpa, J. E., & Lee, W. M. (2006). Regulation of acetyl-CoA carboxylase. Biochemical Society Transactions, 34, 223–227. doi:10.1042/bst0340223
   PubMed Web of Science ®Google Scholar
• Chonan, T., Oi, T., Yamamoto, D., Yashiro, M., Wakasugi, D., Tanaka, H., … Hiratate, A. (2009). (4-Piperidinyl)-piperazine: A new platform for acetyl-CoA carboxylase inhibitors. Bioorganic & Medicinal Chemistry Letters, 19, 6645–6648. doi:10.1016/j.bmcl.2009.10.012
   PubMed Web of Science ®Google Scholar
• Chonan, T., Wakasugi, D., Yamamoto, D., Yashiro, M., Oi, T., Tanaka, H., … Hiratate, A. (2009). (4-Piperidinyl)-piperazine: A new platform for acetyl-CoA carboxylase inhibitors. Bioorganic & Medicinal Chemistry Letters, 19, 6645–6648. doi:10.1016/j.bmcl.2009.10.012
   PubMed Web of Science ®Google Scholar
• Chonan, T., Tanaka, H., Yamamoto, D., Yashiro, M., Oi, Ohoka-Sugita, A., … Hiratate, A. (2010). Design and synthesis of disubstituted (4-piperidinyl)-piperazine derivatives as potent acetyl-CoA carboxylase inhibitors. Bioorganic & Medicinal Chemistry Letters, 20, 3965–3968. doi:10.1016/j.bmcl.2010.04.134
   PubMed Web of Science ®Google Scholar
• Chonan, T., Wakasugi, D., Yamamoto, D., Yashiro, M., Oi, T., Tanaka, H., … Hiratate, A. (2011). Discovery of novel (4-piperidinyl)-piperazines as potent and orally active acetyl-CoA carboxylase 1/2 non-selective inhibitors: F-Boc and triF-Boc groups are acid-stable bioisosteres for the Boc group. Bioorganic & Medicinal Chemistry, 19, 1580–1593. doi:10.1016/j.bmc.2011.01.041
   PubMed Web of Science ®Google Scholar
• Corbett, J. W., Freeman-Cook, K. D., Elliott, R., Vajdos, F., Rajamohan, F., Kohls, D., … Esler, W. (2010). Discovery of small molecule isozyme non-specific inhibitors of mammalian acetyl-CoA carboxylase 1 and 2. Bioorganic & Medicinal Chemistry Letters, 20, 2383–2388. doi:10.1016/j.bmcl.2009.04.091
   PubMed Web of Science ®Google Scholar
• da Silva Gonçalves, A., França, T. C., Caetano, M. S., & Ramalho, T. C. (2014). Reactivation steps by 2-PAM of tabun-inhibited human acetylcholinesterase: Reducing the computational cost in hybrid QM/MM methods. Journal of Biomolecular Structure and Dynamics, 32, 301–307. doi:10.1080/07391102.2013.765361
   PubMed Web of Science ®Google Scholar
• França, T. C., Guimarães, A. P., Cortopassi, W. A., Oliveira, A. A., & Ramalho, T. C. (2013). Applications of docking and molecular dynamic studies on the search for new drugs against the biological warfare agents Bacillus anthracis and Yersinia pestis. Current Computer Aided-Drug Design, 9, 507–517. doi:10.2174/15734099113099990033
   PubMed Web of Science ®Google Scholar
• Haque, T. S., Liang, N., Golla, R., Seethala, R., Ma, Z., Ewing, W. R., … Cheng, D. (2009). Potent biphenyl- and 3-phenyl pyridine-based inhibitors of acetyl-CoA carboxylase. Bioorganic & Medicinal Chemistry Letters, 19, 5872–5876. doi:10.1016/j.bmcl.2009.08.077
   PubMed Web of Science ®Google Scholar
• Harwood Jr., H. J. (2005). Treating the metabolic syndrome: Acetyl-CoA carboxylase inhibition. Expert Opinion on Therapeutic Targets, 9, 267–281. doi:10.1517/14728222.9.2.267
   PubMed Web of Science ®Google Scholar
• Kamata, M., Yamashita, T., Kina, A., Funata, M., Mizukami, A., Sasaki, M., … Fukatsu, K. (2012). Design, synthesis, and structure–activity relationships of novel spiro-piperidines as acetyl-CoA carboxylase inhibitors. Bioorganic & Medicinal Chemistry Letters, 22, 3643–3647. doi:10.1016/j.bmcl.2012.04.047
   PubMed Web of Science ®Google Scholar
• Kim, K. W., Yamane, H., Zondlo, J., Busby, J., & Wang, M. (2007). Expression, purification, and characterization of human acetyl-CoA carboxylase 2. Protein Expression Purification, 53, 16–23. doi:10.1016/j.pep.2006.11.021
   PubMed Web of Science ®Google Scholar
• Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K., & Olson, A. J. (1998). Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computational Chemistry, 19, 1639–1662. doi:10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
   Web of Science ®Google Scholar
• Munday, M. R., & Hemingway, C. J. (1999). The regulation of acetyl-CoA carboxylase a potential target for the action of hypolipidemic agents. Advances in Enzyme Regulation, 39, 205–234. doi:10.1016/S0065-2571(98)00016-8
   PubMedGoogle Scholar
• Tong, L. (2005). Acetyl-coenzyme A carboxylase: Crucial metabolic enzyme and attractive target for drug discovery. Cellular and Molecular Life Sciences, 62, 1784–1803. doi:10.1007/s00018-005-5121-4
   PubMed Web of Science ®Google Scholar
• Virendar, K. K., Michael, K., Volz, J. M., Weldon, S. C., Hanrahan, S., Xu, J., … Brian, H. K. (2009). Characterization of recombinant human acetyl-CoA carboxylase-2 steady-state kinetics. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 1794, 961–967. doi:10.1016/j.bbapap.2009.02.004
   PubMed Web of Science ®Google Scholar
• Vyas, V. K., Bhatt, H. G., Patel, P. K., Jalu, J., Chintha, C., Gupta, N., & Ghate, M. (2013). CoMFA and CoMSIA studies on C-aryl glucoside SGLT2 inhibitors as potential antidiabetic agents. SAR and QSAR in Environmental Research, 24, 519–551. doi:10.1080/1062936X.2012.751553
   PubMed Web of Science ®Google Scholar
• Vyas, V. K., Goel, A., Ghate, M., & Patel, P. (2015). Ligand and structure-based approaches for the identification of SIRT1 activators. Chemico-Biological Interactions, 228, 9–17. doi:10.1016/j.cbi.2015.01.001
   PubMed Web of Science ®Google Scholar
• Zhang, H., Tweel, B., Li, J., & Tong, L. (2004). Crystal structure of the carboxyltransferase domain of acetyl-coenzyme a carboxylase in complex with CP-640186. Structure, 12, 1683–1691. doi:10.1016/j.str.2004.07.009
   PubMed Web of Science ®Google Scholar